In patients with Crohn’s Disease, achieving intestinal ultrasound transmural healing is linked to improved long-term outcomes ...

ANDOVER, Mass., November 22, 2025--(BUSINESS WIRE)--Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and ...

Please provide your email address to receive an email when new articles are posted on . Endologix announced that the FDA has granted approval of its percutaneous transmural arterial bypass system for ...

ANDOVER, Mass., Feb. 23, 2023 /PRNewswire/ -- Transmural Systems the leader in transcatheter electrosurgery for structural interventions announced today successful first-in-human procedure with its ...

Endologix LLC reported 12-month results from the second of two studies of a fully percutaneous, transmural arterial bypass therapy for treating peripheral arterial disease. Presented at this month's ...

IRVINE, Calif.--(BUSINESS WIRE)--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, ...

We describe three preterm neonates with bronchopulmonary dysplasia, pulmonary hypertension and ventricular hypertrophy who incurred subendocardial infarctions, as evidenced by electrocardiographic, ...

PLASMA and serum enzyme-activity alterations have proved useful as laboratory parameters in the diagnosis of myocardial disease. 1 Among the enzymes employed to reflect myocardial necrosis are ...

Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and ...